EFPIA - NEWSLETTER

EFPIA Newsletter 23 October 2025

Europe's choice

Geopolitical shifts are reshaping life sciences. Europe can build on its strengths and lead or stand still and fall behind. What will it choose?

Learn more here.

Recently published

Obesity is among the most pressing public health challenges of this century and one that is posing a significant burden on Europe’s population and health systems.

It is estimated that by 2030 more than 30% of Europeans will live with obesity, with the direct and indirect costs for healthcare systems estimated to reach up to EUR 1,597 billion if no holistic action is taken.

Read the full report here.

Events

31 OCT 2025

Trials@Home Closing Event 2025 Utrecht, Hybrid

Join the conference on 31 October, dedicated to presenting the project’s recommendations on the conduct of DCTs, featuring...

Learn more →

04 NOV 2025

IHI Brokerage Event 2025 Brussels, Belgium

If you’re interested in future IHI funding opportunities, the IHI Brokerage Event is the ideal place to network and...

Learn more →

18 NOV 2025

POLITICO Health Care Summit 2025 Brussels, Belgium

Join us on 18 November during the POLITICO Health Care Summit for the Fireside Chat | Unleashing the Future of Life...

Learn more →

04 DEC 2025

Future-proofing Alzheimer’s care: scaling innovation for a healthier Europe Online

Explore how new therapies and scalable solutions can transform care pathways and strengthen health systems.

Learn more →

What we are reading

INTERVIEW: EU must 'continue to uphold science', says head of drug agency 20 October 2025 (Euractiv)

Factsheet – 30 years of medicines in the EU 19 October 2025 (European Commission)

An EU Commitment towards UNderstanding CANcer 18 October 2025 (UNCAN)

Trials@Home final recommendations cover the conduct of decentralised clinical trials 16 October 2025 (Trials@Home)

Irish pharma sector hails €30m medicines boost and R&D tax credit increase 09 October 2025 (Euractiv)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶